The Johnson & Johnson vaccine has shown 66 percent efficacy overall and that the U.S. has already ordered 100 million doses. The J&J Covid-19 vaccine is likely to approved by early February. Moderna is also seeking permission to increase doses per vial to address the supply chain problem. Former FDA commissioner and Johnson & Johnson board member Dr. Mark McClellan discusses the JNJ vaccine and Moderna’s request for FDA clearance to put more doses in each vaccine vial. CNBC’s Jane Wells reports on the increase in parents having babies at home during the coronavirus pandemic. LA Times White House reporter Eli Stokols reports on the civil war currently taking place in the Republican Party. Plus, NYC restaurants reopen and the Northeast braces for a winter storm.